News and Events

Scientific Conferences

• Twelfth Annual Conference on Vaccine Research
  Annual Vaccine Meeting National Foundation Infectious Diseases
  Baltimore, Maryland, USA
  April 27-29, 2009
  
  
• Fifth Annual Conference on Protein Therapeutics
  Cambridge HealthTech Institute, San Diego, CA, USA
  January 12 - 16, 2009
  
  
• Elsevier Vaccine Second Global Congress
  Boston, MA, USA
  December 7-9, 2008



• U.S. Civilian Research and Defense Foundation
  Brucellosis as a Trans-boundary Infection of Animals and Humans which needs to be Managed by Cooperative Efforts of Different Countries: an International Workshop
  Serpukhov district, Moscow region, Russia
  June 2-4, 2008
  
  
• Eleventh Annual Conference on Vaccine Research
  Annual Vaccine Meeting National Foundation Infectious Diseases
  Baltimore, Maryland, USA
  May 5-7, 2008
  
  
• Elsevier Vaccine: 25 Years of Publication
  Amsterdam, The Netherlands
  December 7-9, 2007
  
  

Recent Publications, Presentations, Workshops, etc.

Tobin GJ, Trujillo JD, Bushnell RV, Lin G, Chaudhuri AR, Long J, Barrera J, Pena L, Grubman, MJ and Nara PL.
Deceptive imprinting and immune refocusing in vaccine design. Vaccine 26:6189-6199, 2008.

Nara PL, Nara D, Chaudhuri AR, Lin G, and Tobin GJ
Perspectives on advancing preventative medicine through vaccinology at the comparative veterinary, human and conservation medicine interface: Not missing the opportunities. Vaccine 26:6200-6211, 2008.

Lin G, Nara PL.
Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein. Curr HIV Res. 5:514-41, 2007 Review.           

January 2009: Dr. Peter L. Nara, President and CEO, "The Antigenic Wall and a New Technology for Deriving New Therapeutic Monoclonal Antibodies", Plenary Address, Fifth Annual Conference on Protein Therapeutics, San Diego, CA, USA.
January 12-16, 2009.

October 2008:: Dr. Peter L. Nara, President and CEO, Seminar: "Deceptive Imprinting of Class II Pathogens: Consequences and Countermeasures" Translational Immunovirology and Biodefense Group Mayo Clinic College of Medicine, Rochester, MN, Oct. 13, 2008

October 2008: Dr. Peter L. Nara, President and CEO, Speaker: “Improving on Mother Nature’s Immunogenicity” Session Chair: "Vaccines, Reviews, and Future Perspectives- Part II." Ehrlich II, 2nd World Congress on Magic Bullets; A Celebration of the 100th Anniversary of the awarding of the Nobel Prize to Paul Ehrlich; Nurnberg, Germany, Oct.3-5, 2008

September 2008: Dr. Peter L. Nara, President and CEO, Seminar: “Deceptive Imprinting and Immune refocusing Technology” Iowa State University Area Proteomics Group Meeting Iowa State University, Sept. 26, 2008

September 2008: Dr. Peter L. Nara, President and CEO, Speaker: “New Approaches to Vaccines and Diagnostic's for Animal Health” Iowa Biotechnology Association Meeting, Iowa State University, IA Sept. 17, 2008

May 2008: Dr. Gregory J. Tobin, Vice President and COO, Speaker, Eleventh Annual Conference on Vaccine Research (NFID)

May 2008: Dr. Peter L. Nara, President and CEO, Symposium Speaker, Conference Co-chair/founder, Eleventh Annual Conference on Vaccine Research (NFID)

April 2008: Dr. Peter L. Nara, President and CEO, Seminar: “Deceptive Imprinting of the Host Immune System: What it means for Vaccine Development” Emory Vaccine Conference Center, Emory University, April 28, 2008

Mar 2008:         Biological Mimetics, Inc. selected as a finalist for Small Business of the Year award, Tech Council of Frederick County, MD.

Feb. 2008 Dr. Peter L. Nara, President and CEO, Named to the Congressional Economic Commission, State of Maryland

Dec. 2007: Dr. Peter L. Nara, President and CEO, Plenary Speaker- 25th anniversary Vaccine Congress, Amsterdam, The Netherlands, Dec. 9-11, 2007.